It might be about time to gear up for a short — or at least time to take some profits off the table. The Procter & Gamble Company (NYSE:PG) made the decision to rehire its old CEO, A.J. Lafley, to replace his handpicked successor Robert McDonald. I see this as a call for concern, given Lafley’s track record as CEO.
P&G is a great company that likely will be around forever, but it’s about to go through a rocky transition period. Here are three reasons why I am bearish on The Procter & Gamble Company (NYSE:PG).
1. Low ROE and ROIC compared to industry
The personal products industry is ultra–competitive, and companies like The Clorox Company (NYSE:CLX), Colgate-Palmolive Company (NYSE:CL), and Kimberly Clark Corp (NYSE:KMB) dominate the space.
It’s difficult for any of these firms to get a firm “leg-up” on the other. As a result, share prices of the industry leaders have moved almost in lockstep.
You will not make a killing on any of these companies because competition keeps margins and prices fairly equal. Investors look to these companies as income plays because of strong dividend yields. The question to investigate is whether these companies can maintain their performance.
When we look at each company’s return on equity and return on invested capital, we see The Procter & Gamble Company (NYSE:PG) lacks in comparison:
Return on Equity
PG Return on Equity data by YCharts.
Return on Invested Capital
PG Return on Invested Capital data by YCharts.
ROIC also measures managerial effectiveness. Companies with high ROIC are able to give back to their shareholders through dividend payouts, repurchasing stock (which increases earnings per share), and reinvesting in operations or businesses, which increases the firm’s return. Scary is the fact that P&G lags its peers in all four of the above time frames.
P&G’s competition
For the longest time, The Procter & Gamble Company (NYSE:PG) dominated the market with little mention of other companies. But certain companies’ recent performances merit discussion.
Kimberly Clark Corp (NYSE:KMB) is the closest of the mentioned companies to P&G’s managerial effectiveness. For a number of reasons, I see now as a time to include Kimberly-Clark in your portfolio. Its revenue growth is at 1.5% and its price is up 18% this year. In terms of retained earnings, net income and earnings per share are both increasing.
Kimberly-Clark does hold a great deal of debt that could halt dividend growth, but I believe the pros outweigh the cons with this one. Kimberly-Clark has increased its dividend by 6% per year for the past 5 years. It currently stands 3.20%, paying $3.24 per share.
As for Clorox and Colgate-Palmolive, both are booming companies.
The Clorox Company (NYSE:CLX) sells its products in more than 100 countries, and many of its brands hold the No. 1 or No. 2 market-share positions in their categories. Clorox recently bumped up its dividend by 11%, marking the 37th consecutive year for dividend increases.
And if 100 countries weren’t high enough, Colgate-Palmolive Company (NYSE:CL) sells its products in 200. A manufacturer of many well-known brands, Colgate-Palmolive has paid dividends for more than 100 years, and increased them for the last 51 years.
In the areas where these companies are succeeding, so has The Procter & Gamble Company (NYSE:PG). But, I see P&G as the least likely to maintain its efficiency, at least for now. At least it’s comforting that P&G isn’t investing in new projects with borrowed money.
Oh, wait. It is.
2. Lafley is back
Lafley initially stepped down from the CEO position in 2009 after handpicking McDonald as his successor. Unfortunately for McDonald, he came in as the recession hit, leaving him with a mess to clean up. In fact, McDonald dealt with the major spending contracts Lafley left behind, namely $54 billion for Gillette. And now the “big spender” is back.